PC
BDSI

Palo Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Palo Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,205
Closed -$81K – 153
2015
Q2 		$81K Buy
+10,205
New +$87.7K 0.06% 124

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Palo Capital's BDSI Position: Q3 2015 in Review

Palo Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2015, closing a stake of 10,205 shares — an estimated $81K sold.

Palo Capital first reported a position in BDSI in Q2 2015 and held it in 1 quarter. The position peaked at $81K in Q2 2015. 131 funds tracked by Wall St. Rank hold BDSI as of Q3 2015.

  • Palo Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2015 after selling out during the quarter.
  • Palo Capital sold 10,205 BioDelivery Sciences International, Inc. shares in Q3 2015, an estimated $81K.
  • Palo Capital first reported a position in BioDelivery Sciences International, Inc. in Q2 2015 and held it in 1 quarter.
  • Palo Capital's BioDelivery Sciences International, Inc. position peaked at $81K in Q2 2015.
  • 131 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2015.

Based on Palo Capital's 13F filing for Q3 2015, filed 12 Nov 2015.